To help the medical graduates from India, aspiring to do their postgraduation in the United Kingdom, the Government of Karnataka has proposed to conduct the Membership of the Royal College of ...

Treatment with tovecimig, formerly known as CTX-009, elicited responses in patients with biliary tract cancer, according to COMPANION-002 study results. The bispecific antibody tovecimig (formerly CTX ...

Sundaram Venkata Ramanan, known to friends and family as “Ramanan”, died peacefully on February 15, at home in West Hartford, Connecticut, with his wife at his side. He was 91. Ramanan was born in ...

A global comparative study on real-world clinical and genomic differences in advanced biliary tract cancer. Extra-hepatic (ehCCA) and intra-hepatic cholangiocarcinomas (iCCA): A genomic landscape ...

A glowing digital brain with chat bubbles on a neon circuit board, illustrating the concept of AI communication and machine learning. Digital Brain on Circuit Board Technology Concept A glowing ...

Medically reviewed by Jay N. Yepuri, MD PBC is a chronic liver disease that damages bile ducts and can lead to liver failure. You can get treatment for PBC to slow disease progression and manage ...

SAN DIEGO — Quantitative magnetic resonance cholangiopancreatography may help assess changes in the biliary tree and aid monitoring of patients with primary sclerosing cholangitis, according to ...

Nov 20 (Reuters) - The U.S. Food and Drug Administration approved Jazz Pharmaceuticals' (JAZZ.O), opens new tab drug for the treatment of a type of biliary tract cancer, the company said on Wednesday.

Ziihera is the first dual HER2-targeted bispecific antibody approved for HER2-positive BTC in the U.S., offering a chemotherapy-free treatment option. The FDA's accelerated approval was based on a 52% ...

Biliary atresia is a rare condition that affects the bile ducts in infants. It can cause bile to build up in the liver, causing damage. It can be life threatening, but treatment may improve ...

Primary sclerosing cholangitis (PSC) is a rare progressive liver disease that damages bile ducts and significantly increases the risk of bile duct cancer, particularly a type called cholangiocarcinoma ...